Orthofix Medical (OFIX) Earnings Date, Estimates & Call Transcripts

$16.51

0.00 (0.00%)

(As of 07/26/2024 ET)

Upcoming Earnings Date: Aug. 6
Before Market Opens
Confirmed
Actual EPS (May. 7): -$0.95 Missed By -$0.41
Consensus EPS (May. 7): -$0.54

OFIX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

OFIX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Porter & Company

My grim warning about AI stocks

Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.

So go here now to read my new report The Big AI Die-Up… while you still can.

Orthofix Medical Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate	Company Guidance
Q1 2024	1	($0.55)	($0.55)	($0.55)
Q2 2024	1	($0.28)	($0.28)	($0.28)
Q3 2024	1	($0.22)	($0.22)	($0.22)
Q4 2024	1	$0.00	$0.00	$0.00
FY 2024	4	($1.05)	($1.05)	($1.05)
Q1 2025	1	($0.25)	($0.25)	($0.25)
Q2 2025	1	($0.04)	($0.04)	($0.04)
Q3 2025	1	($0.04)	($0.04)	($0.04)
Q4 2025	1	$0.15	$0.15	$0.15
FY 2025	4	($0.18)	($0.18)		($0.18)

OFIX Earnings Date and Information

Orthofix Medical last released its earnings data on May 7th, 2024. The medical device company reported ($0.95) earnings per share for the quarter, missing the consensus estimate of ($0.54) by $0.41. The business earned $188.61 million during the quarter, compared to the consensus estimate of $183.40 million. Orthofix Medical has generated ($3.38) earnings per share over the last year (($3.38) diluted earnings per share). Earnings for Orthofix Medical are expected to grow in the coming year, from ($1.72) to ($0.48) per share. Orthofix Medical has confirmed that its next quarterly earnings report will be published on Tuesday, August 6th, 2024. Orthofix Medical will be holding an earnings conference call on Tuesday, August 6th at 8:30 AM Eastern. Interested parties can register for or listen to the call. or dial in at 647-362-9199 with passcode "9556380".

Orthofix Medical Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
8/6/2024 (Confirmed)	-	-	-	-	-	-	-
5/7/2024	Q1 2024	($0.54)	($0.95)	($0.41)	($0.95)	$183.40 million	$188.61 million
3/5/2024	Q4 2023	($0.60)	($0.59)	+$0.01	($0.59)	-	$200.42 million
11/8/2023	Q3 2023	($0.75)	($0.77)	($0.02)	($0.77)	$185.50 million	$184.01 million
8/8/2023	Q2 2023	($0.67)	$0.02	+$0.69	$1.11	$183.80 million	$187.02 million
5/9/2023	Q1 2023	($0.20)	($0.47)	($0.27)	$0.77	$168.80 million	$175.20 million
3/6/2023	Q4 2022	($0.37)	$0.19	+$0.56	$0.73	$121.90 million	$122.23 million
Get the Latest News and Ratings for OFIX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Orthofix Medical and its competitors with MarketBeat's FREE daily newsletter.
11/3/2022	Q3 2022	$0.02	$0.13	+$0.11	$0.79	$111.00 million	$114.00 million
8/5/2022	Q2 2022	$0.07	$0.08	+$0.01	$0.04	$117.40 million	$118.07 million
5/6/2022	Q1 2022	$0.18	($0.10)	($0.28)	$0.02	$104.70 million	$106.42 million
2/25/2022	Q4 2021	$0.13	$0.27	+$0.14	$2.19	$124.90 million	$125.06 million
11/5/2021	Q3 2021	$0.13	$0.10	($0.03)	$0.31	$112.90 million	$112.43 million
8/6/2021	Q2 2021	$0.16	$0.32	+$0.16	$0.52	$109.35 million	$121.39 million
4/30/2021	Q1 2021	$0.07	$0.17	+$0.10	$0.64	$95.40 million	$105.59 million
2/26/2021	Q4 2020	$0.15	$0.44	+$0.29	$1.36	$118.00 million	$117.62 million
11/5/2020	Q3 2020	($0.21)	$0.31	+$0.52	$0.38	$85.85 million	$110.99 million
8/6/2020	Q2 2020	($0.80)	($0.59)	+$0.21	($0.22)	$53.80 million	$73.14 million
5/8/2020	Q1 2020	$0.11	$0.09	($0.02)	($1.14)	$104.50 million	$104.82 million
2/24/2020	Q4 2019	$0.51	$0.51	-	$0.42	$122.90 million	$121.49 million
10/28/2019	Q3	$0.51	$0.41	($0.10)	$2.96	$117.83 million	$113.50 million
8/5/2019	Q2 2019	$0.40	$0.28	($0.12)	$0.59	$115.17 million	$115.85 million

Orthofix Medical Earnings - Frequently Asked Questions

When is Orthofix Medical's earnings date?: Orthofix Medical has confirmed that its next quarterly earnings data will be published on Tuesday, August 6th, 2024. Learn more on OFIX's earnings history.
What guidance has Orthofix Medical issued on next quarter's earnings?: Orthofix Medical issued an update on its FY 2024 earnings guidance on Wednesday, May, 8th. The company issued revenue guidance of $790.0 million-$795.0 million, compared to the consensus revenue estimate of $790.8 million.
Did Orthofix Medical beat their earnings estimates last quarter?: In the previous quarter, Orthofix Medical (NASDAQ:OFIX) missed the analysts' consensus estimate of ($0.54) by $0.41 with a reported earnings per share (EPS) of ($0.95). Learn more on analysts' earnings estimate vs. OFIX's actual earnings.
How much revenue does Orthofix Medical generate each year?: Orthofix Medical (NASDAQ:OFIX) has a recorded annual revenue of $746.64 million.
How much profit does Orthofix Medical generate each year?: Orthofix Medical (NASDAQ:OFIX) has a recorded net income of -$151.40 million. OFIX has generated -$3.38 earnings per share over the last four quarters.
What is Orthofix Medical's EPS forecast for next year?: Orthofix Medical's earnings are expected to grow from ($1.72) per share to ($0.48) per share in the next year.